81.5% for the Bordier, Bio-Rad and Virion\Serion tests, respectively. The Bordier kit was 37 more sensitive than the Bio-Rad kit (p<0.01), which was itself more sensitive than the 38 Virion\Serion kit (p=0.04). The Bordier and Bio-Rad kits had similar specificities (p=0.8), 39 both higher than that of the Virion\Serion kit (p=0.02). The areas under the ROC curves 40 confirmed the superiority of the Bordier kit over the Bio-Rad and the Virion\Serion kits 41 (0.977, 0.951 and 0.897, respectively; p<0.01 for each comparison). In a subset analysis of 42 279 sera tested with the Bordier and Bio-Rad kits and an in-house immunoprecipitin assay 43 (IPD), the Bordier kit had the highest sensitivity (97.7%), but the IPD tended to be more 44 specific (71.2 and 84.7%, respectively; p=0. 10) . 45 The use of recombinant, somatic and metabolic antigens in a single EIA improved the balance 46 between sensitivity and specificity, resulting in an assay highly suitable for use in the 47 diagnosis of chronic and allergic aspergillosis. 
Introduction

50
A. fumigatus is the species most frequently implicated in pulmonary aspergillosis (1, 2) . 51 Chronic pulmonary aspergillosis (CPA) and allergic bronchopulmonary aspergillosis (ABPA) 52 occur in immunocompetent hosts (3-9). CPA usually affects patients with underlying lung 53 disease, such as mycobacterial infections, chronic obstructive pulmonary disease (COPD), 54 ABPA and emphysema (7, 9, 10). It has been estimated that over 4.8 million asthmatic 55 patients worldwide suffer from ABPA and that about 240,000 people in Europe have CPA 56 (11). Patients suffering from asthma or cystic fibrosis (CF) may become sensitized to 57 Aspergillus antigens, resulting in ABPA, Aspergillus-related bronchitis or severe asthma (1, 58 12). Aspergillus antibodies is considered to be an important criterion (1, 2, 6, 7, 12, (14) (15) (16) 
Test performances
157
The performances of the three EIAs when equivocal results were treated as positive are shown 158 in Table 3A . Overall, the sensitivity of the Bordier assay (97%) was significantly higher than 159 that of the Bio-Rad assay (91.7%),which was itself higher than that of the Virion\Serion assay An analysis of test performances by patient category, and after correction for multiple 196 comparisons, indicated that the new Bordier EIA was more sensitive than the Bio-Rad, 197 Virion\Serion and IPD tests for group 5 of the CNPA with a sensitivity at 100% (Table 3A, 198 3B and Figure2). In the other groups of patients, the only differences between sensitivities Table 3A ).
261
The classification of colonised patients remains challenging. We decided to consider 
